MercoPress, en Español
Montevideo, March 28th 2024 - 20:09 UTC
The U.S. Food and Drug Administration's outside advisers will meet on Dec. 10 to discuss whether to authorize the COVID-19 vaccine developed by Pfizer Inc and German partner BioNTech for emergency use, the agency said on Friday. Read full article
Commenting for this story is now closed.If you have a Facebook account, become a fan and comment on our Facebook Page!
Get our news on your inbox! Suscribe
Comments
Disclaimer & comment rulesCommenting for this story is now closed.
If you have a Facebook account, become a fan and comment on our Facebook Page!